Medical Devices

Dermal Fillers Approved by the Center for Devices and Radiological Health

Close up of the nose, cheek, and mouth region of an elderly person

FDA approval is based on the review of data collected from controlled clinical studies that evaluated the safe and effective use of the wrinkle fillers when injected into specified areas of facial tissue.

More information about the FDA approval is based on the review of data collected from controlled clinical studies that evaluated the safe and effective use of the dermal fillers when injected into specified areas of facial tissue.


Materials

Most dermal fillers have a temporary effect, because they contain materials that are absorbed by the body over time. The FDA has approved only one product made from a material that remains in the body and is not absorbed. Some dermal fillers also contain lidocaine, which is intended to decrease pain or discomfort related to the injection.

The materials used in dermal fillers include:

Absorbable (temporary) materials

  • Collagen: Collagen is a type of protein that is a major part of skin and other tissues in the body. Sources of purified collagen used in soft tissue fillers can be from cow (bovine) or human cells. The effects of collagen fillers generally last for 3-4 months. They are the shortest lasting of injectable filler materials.
  • Hyaluronic acid: Hyaluronic acid is a type of sugar (polysaccharide) that is present in body tissues, such as in skin and cartilage. It is able to combine with water and swell when in gel form, causing a smoothing/filling effect. Sources of hyaluronic acid used in dermal fillers can be from bacteria or rooster combs (avian). In some cases, hyaluronic acid used in dermal fillers is chemically modified (crosslinked) to make it last longer in the body. The effects of this material last approximately 6 – 12 months.
  • Calcium hydroxylapatite: Calcium hydroxylapatite is a type of mineral that is commonly found in human teeth and bones. For wrinkle filling in the face or for the hand, calcium hydroxylapatite particles are suspended in a gel-like solution and then injected into the wrinkle in the face or under the skin in the back of the hand. The effects of this material last approximately 18 months. While in the body, calcium hydroxylapatite will be visible in x-rays and may obscure underlying features.
  • Poly-L-lactic acid (PLLA): PLLA is a biodegradable, biocompatible man-made polymer. This material has wide uses in absorbable stitches and bone screws. PLLA is a long lasting filler material that is given in a series of injections over a period of several months. The effects of PLLA generally become increasingly apparent over time (over a period of several weeks) and its effects may last up to 2 years.

Non-absorbable (permanent) materials

  • Polymethylmethacrylate beads (PMMA microspheres): PMMA is a non-biodegradable, biocompatible, man-made polymer. This material is used in other medical devices, such as bone cement and intraocular lenses. PMMA beads are tiny, round, smooth particles that are not absorbed by the body. When used as a soft tissue filler, PMMA beads are suspended in a gel-like solution that contains cow (bovine) collagen and injected into the face.

Unapproved Dermal Fillers

The FDA is aware that unapproved versions of Juvederm, such as Juvederm Ultra 2, 3, and 4 are being sold and distributed in the U.S., including by online retailers. Juvederm is a prescription device that should only be injected and sold by or on the prescription of a licensed health care provider. The FDA is warning health care providers and patients not to use any Juvederm Ultra 2, 3 or 4, because these products are not approved for use in the U.S. As such, the safety and effectiveness of these products cannot be assured. A list of approved products and indications for use in the U.S. can be found in the table below.

The FDA has NOT approved liquid silicone or silicone gel for injection to fill wrinkles or augment tissues anywhere in the body.


Approved Dermal Fillers

The Summary of Safety and Effectiveness Data for each approved dermal filler contains links to additional information about the clinical data the FDA reviewed.  Links to this information can be found under the “Trade Name” column in the table below. This table lists all FDA-approved dermal fillers. It should be noted that not all of the dermal fillers listed below are currently marketed. 

 
Trade Name (with link to additional information) Material Applicant PMA Number Decision Date Approved For
Restylane, Refyne, Restylane Defyne Sodium Hyaluronate Q-Med AB P140029 12/9/2016 Restylane Refyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds (such as nasolabial fold) in patients over the age of 21. Restylane Defyne is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe deep facial wrinkles and folds (such as nasolabial fold) in patients over the age of 21.
JUVEDERM VOLLURE XC Hyaluronic Acid Allergan P110033/S020 3/17/2017 Injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21.
JUVEDERM VOLBELLA XC Hyaluronic
Acid with Lidocaine
Allergan P110033/S018 5/31/2016 Injection into the lips for lip augmentation and for correction of perioral rhytids in adults over the age of 21.
RESTYLANE LYFT WITH LIDOCAINEdisclaimer icon Hylauronic acid with lidocaine Galderma Laboratories P040024 S073 7/1/2015 Moderate to severe facial folds and wrinkles or in patients over the age of 21 who have age-related volume loss.
RESTYLANE SILK Hyaluronic Acid with Lidocaine Valeant Pharmaceuticals North America LLC/Medicis P040024 S072 6/13/2014 Indicated for lip augmentation and dermal implantation for correction of perioral rhytids (wrinkles around the lips) in patients over the age of 21.
JUVEDERM VOLUMA XC Hyaluronic Acid with Lidocaine Allergan P110033 10/22/2013 Deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.

RESTYLANE-L INJECTABLE GEL

Hyaluronic Acid with Lidocaine Medicis Aesthetics Holdings, Inc. P040024 S056 8/30/2012 Injection into the mid to deep dermis for correction of moderate to severe facial wrinkles/folds (such as nasolabial folds) and for lip augmentation in those over the age of 21 years.
BELOTERO BALANCE Hyaluronic Acid Merz Pharmaceuticals P090016 11/14/2011 Injection into facial tissue to smooth wrinkles and folds, especially around the nose and mouth (nasolabial folds).
RESTYLANE INJECTABLE GEL Hyaluronic Acid Medicis Aesthetics Holdings, Inc P040024 S051 10/11/2011 Lip augmentation in those over the age of 21 years.
JUVEDERM ULTRA XC AND JUVEDERM ULTRA PLUS XC Hyaluronic Acid with Lidocaine Allergan P050047 1/7/2010 The addition of 0.3% Lidocaine into Juvederm Ultra and Juvederm Ultra Plus.
SCULPTRA AESTHETIC Poly-L-Lactic Acid (PLLA) Sanofi Aventis U.S. P030050 S002 7/28/2009 Use in shallow to deep nasolabial fold contour deficiencies and other facial wrinkles.
EVOLENCE COLLAGEN FILLER Collagen Colbar Lifescience l P070013 6/27/2008 The correction of moderate to deep facial wrinkles and folds (such as nasolabial folds).
PREVELLE SILK Hyaluronic Acid with Lidocaine Genzyme Biosurgery P030032 S007 2/26/2008 Injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
RADIESSE 1.3CC AND 0.3CC Hydroxylapatite Bioform Medical, Inc P050037 12/22/2006 Restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with HIV.
RADIESSE 1.3CC AND 0.3CC Hydroxylapatite Bioform Medical, Inc P050052 12/22/2006 Subdermal implantation for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
ELEVESS Hyaluronic Acid with Lidocaine Anika Therapeutics P050033 12/20/2006 Use in mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
ARTEFILL Polymethylmethacrylate Beads, Collagen and Lidocaine. Suneva Medical, Inc. P020012 10/27/2006 Use in facial tissue around the mouth (i.e., nasolabial folds).
JUVEDERM 24HV, JUVEDERM 30, and JUVEDERM 30HV Hyaluronic Acid Allergan P050047 6/2/2006 Use in mid to deep dermis for correction of  moderate to severe facial wrinkles and folds (such as nasolabial folds).
RESTYLANE INJECTABLE GEL Hyaluronic Acid Medicis Aesthetics Holdings, Inc P040024 3/25/2005 Injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
CAPTIQUE INJECTABLE GEL Hyaluronic Acid Genzyme Biosurgery P030032 S002 11/12/2004 Injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
SCULPTRA Poly-L-Lactic Acid (PLLA) Sanofi Aventis U.S. P030050 8/3/2004 Restoration and/or correction of the signs of facial fat loss (facial lipoatrophy) in people with Human Immunodeficiency Virus (HIV).
HYLAFORM (HYLAN B GEL) Modified hyaluronic acid derived from a bird (avian) source Genzyme Biosurgery P030032 4/22/2004 Injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
RESTYLANE INJECTABLE GEL Hyaluronic Acid Q-med Ab P020023 12/12/2003 Injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
COSMODERM 1 HUMAN-BASED C Collagen Inamed Corporation P800022 S050 3/11/2003 Injection into the superficial papillary dermis for correction of soft tissue contour deficiencies, such as wrinkles and acne scars.
FIBREL Collagen Serono Laboratories P850053 2/26/1988 The correction of depressed cutaneous scars which are distendable by manual stretching of the scar borders.
ZYPLAST(R) Collagen Collagen Corp. P800022 S011 6/24/1985 Use in mid to deep dermal tissues for correction of contour deficiencies.
ZYDERM COLLAGEN IMPLANT Collagen Allergan P800022 9/18/1981 Use in the dermis for correction of contour deficiencies of this soft tissue.
RADIESSE Hydroxylapatite Bioform Medical, Inc. P050052/S049 6/4/2015 Subdermal implantation for hand augmentation to correct volume loss in the dorsum of the hands.

Page Last Updated: 08/22/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English